Video Description

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday. The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. It also came as Washington was facing a federal government shutdown at midnight amid a standoff between Democrats and Republicans over health care and its costs. READ MORE: https://www.wcnc.com/article/syndication/associatedpress/pfizer-agrees-to-lower-prescription-drug-costs-for-medicaid-in-a-deal-with-trump/616-4fb3e4bb-d930-41fe-9510-1913a6743e66